About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

10 Am. J. Bioethics 1 (2010)

handle is hein.journals/ajbio10 and id is 1 raw text is: 


The American Journal of Bioethics, 10(1): 1-8, 2010
Copyright c Taylor & Francis Group, LLC
ISSN: 1526-5161 print / 1536-0075 online
DOI: 10.1080/15265160903440998


    The Pitfalls of Deducing Ethics From

            Behavioral Economics: Why the

         Association of American Medical

                     Colleges Is Wrong About

                     Pharmaceutical Detailing

                Thomas S. Huddle, University of Alabama School of Medicine


The Association of American Medical Colleges (AAMC) is urging academic medical centers to ban pharmaceutical detailing. This policy followed from a consideration
of behavioral and neuroeconomics research. I argue that this research did not warrant the conclusions drawn from it. Pharmaceutical detailing carries risks of cognitive
error for physicians, as do other forms of information exchange. Physicians may overcome such risks; those determined to do so may ethically engage in pharmaceutical
detailing. Whether or not they should do so is a prudential judgment about which reasonable people may disagree. The AAMC's ethical condemnation of detailing is
unwarranted and will subvert efforts to maintain a realm of physician discretion in clinical work that is increasingly threatened in our present practice environment.
Keywords: academic medicine, behavioral economics, medical ethics, medical professionalism, pharmaceutical detailing, pharmaceutical industry


Medicine's relations with industry have long been a topic
of controversy within academic medicine, and direct phar-
maceutical advertising to physicians, also known as phar-
maceutical detailing, has been a special target of criticism.
Criticism of detailing intensified with the turn of the new
century, and recently critics have begun to make progress at
the organizational level. In 2006 a call for an academic ban
on detailing appeared in the Journal of the American Medi-
cal Association (Brennan et al. 2006), and the Association of
American Medical Colleges (AAMC) charged a task force
that took up this and other aspects of academic medicine's
relations with industry. In the past 2 years a number of
academic medical centers have banned detailing (Rothman
and Chimonas 2008). The AAMC task force issued a re-
port in 2008 that condemned detailing practices as unethical
(Association of American Medical Colleges, 2008a). Shortly
thereafter, the report was unanimously approved by the
Association's Executive Council (Association of American
Medical Colleges 2008b), and the AAMC is now encour-
aging medical schools that have not yet implemented the
report's recommendations to do so.
   Until recent years the academic case against detailing
has depended upon studies examining bias in industry ad-
vertising and its effects on physicians. As summarized by
Wazana in a widely quoted meta-analysis (Wazana 2000),
this literature suggests that detailing induces physicians to
prescribe new drugs too rapidly, to request the addition to


formularies of drugs that offer no advantage over existing
drugs, and to prescribe fewer generic drugs. Such conclu-
sions have a good deal of face validity for many physicians,
who, whether or not they participate in detailing, agree that
information from drug representatives is inevitably biased
(Manchanda and Honka 2005; Prosser and Walley 2003).
Skepticism about detailing is also fueled by well-publicized
detailing misconduct by pharmaceutical companies, such
as Parke-Davis's improper promotion of gabapentin for off-
label uses in the late 1990s (Steimnan et al. 2007), as well as
by what appears to have been over-zealous industry pro-
motion of drugs that did not live up their promise, such as
the Cox-2 inhibitors.
    The AAMC did not particularly rely upon the Wazana
studies in formulating its recommendations on medicine-
industry relations. It turned instead to a new line of criticism
of detailing that has emerged in the past 10 years or so: so-
cial science in the form of behavioral and neuroeconomics.
Rather than focusing on conscious corruption occurring
through conflict of interest, critics informed by behavioral
economics suggest that unconscious influence exerted by
advertising and promotional gifts on physician decision
making inevitably bias physician decisions-and that the
necessary remedy is avoidance of the gifts and the adver-
tising (Dana and Loewenstein 2003; Katz et al. 2003).
    I argue that the behavioral economists have over-
generalized from their data in drawing conclusions about


ajob 1


Address correspondence to Thomas S. Huddle, Division of General Internal Medicine, UAB School of Medicine, 1530 3rd Avenue South,
FOT 720, Birmingham, AL 35294, USA. E-mail: thuddle@uab.edu

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline.

Contact us for annual subscription options:

Already a HeinOnline Subscriber?

profiles profiles most